2013
Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: New trends and future opportunities
Cruz R, Ranganathan S, Mazariegos G, Soltys K, Nayyar N, Sun Q, Bond G, Shaw P, Haberman K, Krishnamurti L, Marsh J, Humar A, Sindhi R. Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: New trends and future opportunities. Surgery 2013, 153: 150-159. PMID: 23331862, DOI: 10.1016/j.surg.2012.11.006.Peer-Reviewed Original ResearchConceptsTumor histologyLiver transplantationNational Cancer Institute's SurveillanceFavorable tumor histologyHepatic artery thrombosisEnd Results registryUnresectable liver malignanciesDeterminants of survivalLTx centersPosttransplantation outcomesArtery thrombosisNonmalignant indicationsPulmonary metastasesSurgical resectionChildren's HospitalPatient survivalTumor lysisUnited NetworkLiver malignanciesTumor necrosisAntithrombotic agentsOrgan SharingHepatoblastoma casesLTxStage III
2003
Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies
Krishnamurti L, Abel S, Maiers M, Flesch S. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies. Bone Marrow Transplantation 2003, 31: 547-550. PMID: 12692619, DOI: 10.1038/sj.bmt.1703887.Peer-Reviewed Original ResearchConceptsHematopoietic stem cell transplantationNational Marrow Donor ProgramStem cell transplantationUnrelated donorsHemoglobinopathy patientsCell transplantationThalassemia patientsURD HSCTLife-threatening blood diseaseSickle cell disease patientsUnrelated bone marrow donorsUmbilical cord blood unitsHLA-identical siblingsOnly curative optionCord blood unitsBone marrow donorsCurative optionPreparative regimensHLA matchDisease patientsPotential HLAMarrow donorsNMDP RegistryPatientsVolunteer donors